Search Results 531-540 of 18389 for total bilirubin

1. A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations - Mayo Clinic

   Serum total bilirubin ≤ 1.5 x ULN (< 3.0 x ULN for participants with documented Gilbert's syndrome);; ALP ≤ 2.5 x ULN (≤ 5 x ULN in case of bone ...

2. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

   For HCC: Serum bilirubin >2.0 mg/dl (unless segmental infusion is planned47); For other primary or secondary liver neoplasis, bilirubin levels will be ...

3. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Total bilirubin ≤ 1.5 institutional upper limit of normal (ULN); Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) and ...

4. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Note: Subjects with borderline serum pregnancy test at Screening must have a serum ... Total bilirubin ≥2 mg/dL; except for subjects with isolated elevation of ...

5. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

   Total bilirubin ≤ 1.5 x upper limit of normal (ULN) (except patients with Gilbert Syndrome, who can have total bilirubin < 3.0 mg/dL);; Aspartate ...

6. Axicabtagene Ciloleucel Expanded Access Study - Mayo Clinic

   Serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ≤2.5 ... Total bilirubin ≤1.5 mg/dL, except in subjects with Gilbert's syndrome; ...

7. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

   Participation eligibility · Serum AST or ALT > 3.0 × upper limit of normal (ULN) with a total bilirubin > 2 × ULN or international normalized ratio (INR) > 1.5 ...

8. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis - Mayo Clinic

   Total bilirubin, AST, ALT, and alkaline phosphatase levels <2 times the upper limit of normal; Hemoglobin >7.0 gm/dL, white count >3.0 X 10(9), platelet ...

9. ETHAN - ET for Male BC - Mayo Clinic

   * Serum creatinine ≤ 3.0 x ULN (institutional) * Total bilirubin ≤ 2.0 x ULN (institutional). * AST and ALT ≤ 5.0 x ULN (institutional) * Men with ...

10. Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation - Mayo Clinic

    Serum amylase and lipase ≤ 1.5 x upper limit of normal (ULN); Total bilirubin ≤ 1.5 x ULN (does not apply to patients with isolated hyperbilirubinemia ...